Figure 2. Subgroup analyses comparing fluvoxamine–budesonide versus matched placebo.

In the prespecified subgroup analyses, we found consistent evidence of treatment benefits with fluvoxamine–budesonide compared with matched placebo. BMI = body mass index; CrI = credible interval; ITT = intention-to-treat.